Certificate Reference
For continuity with the current catalog, this page links to laboratory documentation for a component or a closely related product. The linked certificate is a reference only and is not represented as the batch-specific COA for AHK-Cu.
Overview
AHK-Cu is a copper-binding tripeptide complex studied for its interaction with dermal papilla cells, fibroblast signaling, and tissue-remodeling pathways. It is especially relevant where researchers want a compact copper-peptide model with measurable cellular endpoints.
Research Reference: View compound profile on NIH PubChem
Research Focus
WHAT THIS FORMULA FEATURES
A short peptide coordinated with copper(II), combining a defined metal-binding structure with biological activity in cultured dermal cells. Published work has reported stimulation of dermal papilla-cell proliferation and elongation of human hair follicles in ex-vivo models.
EXPECTED RESEARCH READOUTS
Common endpoints include dermal papilla-cell proliferation, apoptosis markers, hair-follicle elongation in ex-vivo models, VEGF-related signaling, and fibroblast-response assays. Results are model-dependent and should be compared with appropriate copper and peptide controls.
Research endpoints described above reflect published or model-based scientific observations and are not guaranteed outcomes. This product is strictly for research purposes only. Not approved for human or animal use.
Key Characteristics
MOLECULAR PROFILE
Formula: C15H24ClCuN6O4 (PubChem monohydrochloride record)
Weight: 451.39 g/mol (PubChem monohydrochloride record)
CAS: 682809-81-0
PubChem CID: 168431292
Classification: Copper tripeptide complex
PHYSICAL PROPERTIES
Form: Lyophilized powder
Catalog strengths: 50 mg | 100 mg
Purity specification: ≥99% catalog specification; verify current batch COA
Storage: Store at −20°C (−4°F) for long-term storage or 4°C (39°F) for short-term storage; avoid repeated freeze-thaw cycles.
Testing: Batch documentation should be verified against the current lot before analytical use.
